EP Patent

EP1915334A2 — Novel salts of fumaric acid monoalkylesters and their pharmaceutical use

Assigned to ADITECH PHARMA AG · Expires 2008-04-30 · 18y expired

What this patent protects

The present invention relates to novel amino acid salts of fumaric acid monoalkylesters. The salts are suitable for use as active substances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders.

USPTO Abstract

The present invention relates to novel amino acid salts of fumaric acid monoalkylesters. The salts are suitable for use as active substances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP1915334A2
Jurisdiction
EP
Classification
—
Expires
2008-04-30
Drug substance claim
No
Drug product claim
No
Assignee
ADITECH PHARMA AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.